G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2006
10/25/2006	EP1715063A2 Hybridisation beacon and method of rapid sequence detection and discrimination
10/25/2006	EP1715062A2 Method for detecting human papillomavirus mRNA
10/25/2006	EP1715060A1 Method, reagent, and kit for determining cholesterol in very-low-density lipoprotein remnant (vldl remnant)
10/25/2006	EP1715059A1 Method for the identification of possibly harmful receptor tyrosine kinase (RTK) mutations and of inhibitors or medication directed against RTK mutants
10/25/2006	EP1715043A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/25/2006	EP1715038A1 Antibody targeting osteoclast-associated protein
10/25/2006	EP1714982A2 Methods for purifying highly anionic proteins
10/25/2006	EP1714981A2 Method for the identification of antigenic peptides
10/25/2006	EP1714978A1 Peptides useful for diagnosis and therapy of tumors
10/25/2006	EP1714974A2 HIV-1-and HIV-2-peptides for inhibition of membranes fusion-associated events, including HIV transmission
10/25/2006	EP1714699A1 System for analyzing a plurality of samples
10/25/2006	EP1714160A1 Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
10/25/2006	EP1714159A2 Cjd prion testing
10/25/2006	EP1714158A2 Methods of diagnosing acute coronary syndrome by measuring urotensin ii
10/25/2006	EP1714157A2 Method for identifying and quantifying of tumour-associated peptides
10/25/2006	EP1714156A1 Diagnostics and therapeutics for diseases associated with phosphate regulating endopeptidase homolog (phex)
10/25/2006	EP1714155A1 Non-invasive real-time in vivo bioluminescence imaging of local ca2+ dynamics in living organisms
10/25/2006	EP1714154A2 Diagnostics and therapeutics for diseases associated with plasma glutamate carboxypeptidase (pgcp)
10/25/2006	EP1714153A2 A polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
10/25/2006	EP1714152A2 Monoclonal antibody based biomarker discovery and development platform
10/25/2006	EP1714151A2 Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity
10/25/2006	EP1714150A2 Method for the detection of early b cell populations in vaccine development
10/25/2006	EP1714149A1 Throughflow device for measuring platelet function of primary hemostasis, aggregation and/or coagulation and/or viscosity of blood
10/25/2006	EP1714148A1 Electrochemical biosensor
10/25/2006	EP1714147A1 Fluid testing sensor having vents for directing fluid flow
10/25/2006	EP1714146A2 Method of measurement of nucleated red blood cells
10/25/2006	EP1714145A1 Apparatus for detecting drugs in a beverage
10/25/2006	EP1714144A2 High throughput screening methods for fuel compositions
10/25/2006	EP1714139A2 Use of two-photon excited fluorescence in assays of clinical chemistry analytes
10/25/2006	EP1714137A1 Method for determining clinical and/or chemical parameters in a medium and device for carrying out said method
10/25/2006	EP1714135A2 Apparatus and process for sensing target gas species in semiconductor processing systems
10/25/2006	EP1714131A1 A pump for supplying a gas to a sensor and methods therefor
10/25/2006	EP1713935A1 Modulation of hsv infection
10/25/2006	EP1713933A1 Vesicle used to separate substances from liquid media
10/25/2006	EP1713929A2 Diagnostics and therapeutics for diseases associated with plasma kallikrein (klkb1)
10/25/2006	EP1713927A2 Diagnostics and therapeutics for diseases associated with puromycin sensitive aminopeptidase npepps (npepps)
10/25/2006	EP1713900A2 Methods and systems for annotating biomolecular sequences
10/25/2006	EP1713832A1 Method for improving a polymerization reaction by taking out and analysing a sample
10/25/2006	EP1713829A2 Antibody for diagnosing and treating neuropsychiatric diseases, in particular schizophrenia, depression and bipolar affective disorders
10/25/2006	EP1713827A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
10/25/2006	EP1713824A2 Recombinant viruses with heterologous envelope proteins
10/25/2006	EP1713821A2 Primary central nervous system tumor specific behab isoforms
10/25/2006	EP1713811A1 Use of phthalocyanines as marking substances for liquids
10/25/2006	EP1713589A1 Test element and method for testing blood
10/25/2006	EP1713501A1 Treatment of neurodegenerative diseases by the use of gpr49
10/25/2006	EP1713499A1 Methods and compounds for modulating triglyceride and vldl secretion
10/25/2006	EP1713495A2 Method of inducing or modulating immune response
10/25/2006	EP1623211A4 Systems and methods for monitoring chemical and biolgical activities using differential measurements
10/25/2006	EP1606628B1 Ph-dependent polypeptide aggregation and its use
10/25/2006	EP1558293A4 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
10/25/2006	EP1546374A4 Method for detecting transferase enzymatic activity
10/25/2006	EP1546368A4 Analytical method for the determination of infant formula protein digestibility in vitro
10/25/2006	EP1512012B1 Biomolecular kinetics method using a flow-through microarray
10/25/2006	EP1507869A4 Improved receptor detection
10/25/2006	EP1501925A4 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis
10/25/2006	EP1495321A4 Human metabolic models and methods
10/25/2006	EP1423417B1 Antibodies recognizing a peptide mimicking a cryptic epitope of gp41 of hiv-1
10/25/2006	EP1409525B1 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket
10/25/2006	EP1401416B1 Use of c-kit inhibitors for treating inflammatory bowel diseases (ibd)
10/25/2006	EP1399066B1 Devices for the expression of bodily fluids from an incision
10/25/2006	EP1373308B1 Antagonist for multimerization of hiv-1 vif protein
10/25/2006	EP1332155B1 Immunization of dairy cattle with gapc protein against streptococcus infection
10/25/2006	EP1311851B1 Screening method for discovering auxiliary agents promoting endocytosis
10/25/2006	EP1254181B1 Diagnostic assay for type 2 heparin-induced thrombocytopenia
10/25/2006	EP1235805B1 Immunoassay for neonicotinyl insecticides
10/25/2006	EP1204737B1 Internal quality control
10/25/2006	EP1203236B1 Methods for simultaneously detecting both members of a binding pair
10/25/2006	EP1190258B1 Assay for degp protease inhibitors
10/25/2006	EP1181551B1 Products and methods for single parameter and multiparameter phenotyping of cells
10/25/2006	EP1173768B1 Methods of diagnosing, prognosing, monitoring the progression or evaluating of a treatment of depression on basis of increased cerebrospinal fluid levels of neurotrophin 3
10/25/2006	EP1161672B1 A device for detecting the presence of chemical contaminants
10/25/2006	EP1153302B1 Diagnostics and therapeutics for macular degeneration
10/25/2006	EP1148947B1 Fibre array for contacting chemical species and methods for using and making same
10/25/2006	EP1129112B1 Peptides containing a cholesterol recognition sequence and their uses
10/25/2006	EP1109901B1 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF
10/25/2006	EP1107993B1 Human monoclonal antibodies directed against the islet cell antigen ia-2
10/25/2006	EP1104488B1 Linking gene sequence to gene function by three dimensional (3d) protein structure determination
10/25/2006	EP1097167B1 Neurotrophic growth factor
10/25/2006	EP1073897A4 Lifetime-based sensing of sodium and potassium
10/25/2006	EP1034427B1 Method for detecting and monitoring of chemical species
10/25/2006	EP1032839B2 Apparatus for automatic implementation of the pcr method
10/25/2006	EP1016866B1 Novel compound 2-amino-3-[2-(alpha-mannopyranosyl) indol-3-yl] propionic acid, process for preparing the same, and method for inspecting function of living body with the novel compound
10/25/2006	EP0993614B1 Device for determination of an analyte in a body fluid
10/25/2006	EP0973802B1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
10/25/2006	EP0929662B1 Cell culture media for mammalian cells
10/25/2006	EP0912086B1 Method of screening for drugs for the treatment of alzheimer's disease
10/25/2006	EP0828849B1 High-affinity oligonucleotide ligands to pdgf
10/25/2006	EP0821791B1 Methods and apparatus for ultrafast electroseparation analysis
10/25/2006	CN2831121Y Mycoplasma pneumoniae antibody detection reagent paper
10/25/2006	CN2831120Y One-machine two-purpose Masher stability tester
10/25/2006	CN2831119Y Electrode gripper for treatment of molten metal
10/25/2006	CN2831118Y Evaluator for material pyrolytic flue toxicity
10/25/2006	CN2831115Y Multi-channel microflow controlled chip
10/25/2006	CN2831113Y Multifunction radio detetor
10/25/2006	CN2831085Y One-machine two-purpose Marshall automatic impact instrument
10/25/2006	CN1853104A Protocol and apparatus for determining heparin-induced thrombocytopenia
10/25/2006	CN1853103A Support element for use in the analysis of substances
10/25/2006	CN1853102A High throughput method to identify ligands for cell attachment
10/25/2006	CN1853101A 反应条件传感器 Reaction condition sensor
10/25/2006	CN1853100A Iconic colorimetric test device with reduced susceptibility to false positive and false negative readings

1 ... 1794 1795 1796 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 1813 1814 ... 3937